US Patent Issued to BRACCO IMAGING on July 15 for "1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(III) complexes for use as MRI contrast agents" (Italian Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,880, issued on July 15, was assigned to BRACCO IMAGING S.P.A. (Milan).

"1,4-bis-(2-hydroxy-benzyl)-1,4,7-triazacyclononane derivatives and similar compounds as ligands in iron(III) complexes for use as MRI contrast agents" was invented by Mauro Botta (Turin, Italy), Lorenzo Tei (Turin, Italy), Fabio Carniato (Alessandria, Italy), Zsolt Baranyai (Trieste, Italy) and Mariangela Boccalon (Terzo d'Aquileia, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to the novel compounds of formula (I) as well as ions, stereoisomers, tautomers, hydrates, solvates, pharmaceutically acceptable salts thereof, or mixtures of the same. The co...